Connor, Clark & Lunn Investment Management (CC&L)’s Oric Pharmaceuticals ORIC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12,832
| Closed | -$132K | – | 1572 |
|
|
2024
Q3 | $132K | Buy |
+12,832
| New | +$132K | ﹤0.01% | 1356 |
|
|
2023
Q2 | – | Sell |
-43,225
| Closed | -$246K | – | 1441 |
|
|
2023
Q1 | $246K | Buy |
43,225
+1,590
| +4% | +$9.06K | ﹤0.01% | 1049 |
|
|
2022
Q4 | $245K | Sell |
41,635
-9,174
| -18% | -$54K | ﹤0.01% | 1013 |
|
|
2022
Q3 | $163K | Buy |
50,809
+29,746
| +141% | +$95.4K | ﹤0.01% | 1008 |
|
|
2022
Q2 | $94K | Buy |
+21,063
| New | +$94K | ﹤0.01% | 983 |
|